Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 5.924.893 | 1.095.803 | 1 |
Institution: | Projects [No]: |
---|---|
APITOPE INTERNATIONAL NV | 1 |
GLAXOSMITHKLINE BIOLOGICALS | 1 |
KWS BIOTEST LIMITED | 1 |
Total number of partners: 3
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 3
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-12-01 | "The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease." | DAVIAD | participant | 5.924.893 | 4 |